Merck CEO Robert Davis presentation at the Goldman Healthcare CEOs conference last week. The biggest takeaway is that strengthening keytruda js a key priority. And that good takeover targets still are negotiating hard despite the market conditions
https://event.webcasts.com/starthere.jsp?ei=1590161&tp_key=4727c9fb98&tp_special=8
Merck CEO Robert Davis presentation at the Goldman Healthcare...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 827 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 827 | 2 |
View Market Depth
| Last trade - 09.43am 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable